Open Access<p>Definition and Identification of Patients with Treatment-Resistant Depression in Real-World Clinical Practice Settings Across Asia</p>
Author(s) -
Changsu Han,
Gang Wang,
Sandra L. Chan,
Takeshi Kato,
Chee H. Ng,
Wilson M. Tan,
Lili Zhang,
Yu Feng,
Chia-Yih Liu
Publication year - 2020
Publication title -
neuropsychiatric disease and treatment
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.819
H-Index - 67
eISSN - 1178-2021
pISSN - 1176-6328
DOI - 10.2147/ndt.s264799
Subject(s) - medicine , antidepressant , depression (economics) , depressive symptoms , major depressive episode , clinical practice , psychiatry , family medicine , anxiety , hydrocortisone , hippocampus , economics , macroeconomics
An Asia-Pacific expert consensus defined treatment-resistant depression (TRD) as failure of ≥2 antidepressants given at adequate doses for 6-8 weeks during a major depressive episode. A survey examined how TRD was being diagnosed in real-world practices across Asia. An expert panel then interpreted the results and provided practical recommendations.